- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr. Martens PLC (DOCS)
The Dr. Martens share price today is 64.10 %REPORT_CURRENCY%, view LON DOCS stock exchange data. Track the latest Dr. Martens share price with real-time updates on DOCS stock performance including market cap, day range, 52-week range and dividend yield. Access DOCS charts, earnings dates and analyst estimates to support your investment decisions.
64.10
-2.40(-3.61%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
64.10
66.10
52 wk Range
51.30
100.80
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
64.1066.10
52 wk Range
51.30100.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DOCS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
103.50
Upside
+61.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens PLC Earnings Call Summary for Q3/2026
- Dr. Martens reported strong wholesale growth across all regions for the first time in three years, with revenue and profit before tax showing significant YoY growth despite reduced promotional activity.
- The company is executing a strategic pivot toward sustained profitable growth, reducing off-price deals and optimizing distribution while maintaining impressive 90.2% gross profit margins.
- New product launches including Chesney boots and Dunnet Flower sandals contributed positively, with the company expressing confidence in turning the boots category positive.
- CEO Ije Nwokorie described 2026 as 'a year of pivot' with forward guidance projecting EPS of $1.68 for FY2026 and $1.86 for FY2027.
- Currently trading at $37.29 (significantly below earlier $67.35), with next earnings report due February 5, 2026, and InvestingPro analysis suggesting the stock is undervalued.
Last Updated: 03-02-2026, 03:50 am
Read Full TranscriptCompare DOCS to Peers and Sector
Metrics to compare | DOCS | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipDOCSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 40.5x | 10.1x | 10.8x | |
PEG Ratio | −0.82 | 0.12 | 0.02 | |
Price/Book | 1.9x | 1.7x | 1.4x | |
Price / LTM Sales | 0.8x | 1.0x | 0.9x | |
Upside (Analyst Target) | 59.9% | 38.7% | 28.2% | |
Fair Value Upside | Unlock | 21.0% | 11.1% | Unlock |
Analyst Ratings
3 Buy
3 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 103.50
(+61.47% Upside)
Earnings
Latest Release
20-11-2025
EPS / Forecast
-0.01 / -0.01
Revenue / Forecast
322M / 331.78M
FAQ
What Is the Dr. Martens (DOCS) Share Price Today?
The Dr. Martens share price today is 64.10 GBP.
What is the current Dr. Martens (DOCS) share price and day range?
As of 25-04-2026, the Dr. Martens share price is 64.10 GBP, with a previous close of 66.50 GBP. The share price has ranged from 64.10 to 66.10 GBP today, while the 52-week range spans from 51.30 to 100.80 GBP.
What Is the Dr. Martens Market Cap?
As of today, Dr. Martens market cap is 620.15M.
Does Dr. Martens Pay Dividends? What's The Current Dividend Yield?
The Dr. Martens dividend yield is 3.83%.
What Is the Dr. Martens (DOCS) Share Price Target?
The average 12-month share price target for Dr. Martens is 103.50 GBP, with a high estimate of 141 GBP and a low estimate of 76 GBP. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +61.47% Upside potential.
What Is Dr. Martens's Earnings Per Share (TTM)?
The Dr. Martens EPS (TTM) is 0.02.
When Is the Next Dr. Martens Earnings Date?
Dr. Martens will release its next earnings report on 19-05-2026.
From a Technical Analysis Perspective, Is DOCS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Dr. Martens Trade On?
Dr. Martens is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Dr. Martens?
The stock symbol for Dr. Martens is "DOCS."
How Many Times Has Dr. Martens Stock Split?
Dr. Martens has split 0 times.
How Many Employees Does Dr. Martens Have?
Dr. Martens has 3700 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.